Press releases worldwide
European microphysiological systems (MPS) industry leaders, AlveoliX (Switzerland); BiomimX (Italy); chiron (Netherlands) Dynamic42 (Germany); InSphero (Switzerland); MIMETAS (Netherlands) NETRI (France), React4Life (Italy) and TissUse (Germany), are announcing today the creation of the Industry Alliance for Microphysiological Systems (IAMPS), the world’s […]
In a first-of-its-kind initiative, TissUse (a leader in organ-on-chip technology) announced the commencement of the Liver Ring Trial. This collaborative effort involving ESQLabs (a computational model expert), UCB, a global biopharmaceutical company and initiator of the ring trial, and five […]
TissUse will receive funding from the Bill & Melinda Gates Foundation to develop a human preclinical lung-liver-lymph node co-culture on a HUMIMIC Chip infectable with Mycobacterium tuberculosis. This collaboration will contribute to the development of Tuberculosis vaccine candidates and treatment. […]
PMI and TissUse have signed a collaboration agreement to utilize PMI’s InHALES technology in combination with TissUse’s proprietary Multi-Organ-Chip (MOC) platform to enable inhalation exposure of functional human tissues in homeostasis at minute scale in vitro. The two partners will […]
On its 10th company anniversary, TissUse GmbH appoints Dr. Reyk Horland, previously VP Business Development, as the new CEO. Reyk Horland has been with TissUse since it was founded in 2010 and has implemented a profitable product business with a […]
TissUse – the leading pioneer of the Multi-Organ-Chips technology enabling highly predictive substance testing has been awarded the ISO EN 9001-2015. The ISO 9001-2015 is a globally recognized standard that certifies quality management systems focused on ongoing improvements, customer satisfaction and implementing […]
TissUse, the Berlin-based pioneers in Human-on-a-Chip developments, have launched their new product brand HUMIMIC. From now on, all of the company’s products will be marketed under this common brand. As a result, TissUse GmbH’s products will have a uniform name […]
For the first time, TissUse has granted development and distribution rights of its existing Smart Hair Transplant (SHT) technology to J. Hewitt, a Japan-based biopharmaceutical company focused on creating transformative regenerative medicine for aesthetic surgery. Under the terms of this […]
TissUse has signed a collaboration agreement with Bayer to develop a highly innovative liver-endocrine tissues assay using TissUse’s Multi-Organ-Chip (MOC) technology. Under the terms of the collaboration agreement, TissUse will join forces with Bayer to develop a novel mechanistic in […]
TissUse and Roche have signed a cooperating agreement to develop human-relevant in vitro assays based on TissUse’s Multi-Organ-Chip technology. Under the terms of the collaboration agreement, TissUse will provide its Multi-Organ-Chip (MOC) technology as a highly versatile tool to develop […]